(5Z)-5-(1,3-Benzodioxol-5-ylmethylidene)-2-methylamino-3,5-dihydro-4H-imidazol-4-one

ID: ALA5200677

PubChem CID: 136486945

Max Phase: Preclinical

Molecular Formula: C12H11N3O3

Molecular Weight: 245.24

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC1=N/C(=C\c2ccc3c(c2)OCO3)C(=O)N1

Standard InChI:  InChI=1S/C12H11N3O3/c1-13-12-14-8(11(16)15-12)4-7-2-3-9-10(5-7)18-6-17-9/h2-5H,6H2,1H3,(H2,13,14,15,16)/b8-4-

Standard InChI Key:  DOWFKLSBHHHHTF-YWEYNIOJSA-N

Molfile:  

 
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -1.9240    0.6596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3363   -0.0549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7866   -0.6871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0445   -0.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1269    0.4672    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3298   -0.7421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3848   -0.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0994   -0.7421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8140   -0.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6111   -0.6047    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0784    0.0824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6111    0.7421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8140    0.4947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0994    0.9069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3848    0.4947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9514   -1.4842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2538    1.4017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0784    1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  2  0
  4  6  2  0
  6  7  1  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
  9 13  1  0
 12 13  1  0
 13 14  2  0
  7 15  2  0
 15 14  1  0
  3 16  2  0
  1 17  1  0
 17 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5200677

    ---

Associated Targets(Human)

DYRK1A Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 1A (6484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK1B Tchem Dual specificity tyrosine-phosphorylation-regulated kinase 1B (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK3 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 3 (1018 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase 2 (358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GSK3-beta Glycogen synthase kinase-3 (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clk4 Dual specificity protein kinase CLK4 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clk3 Dual specificity protein kinase CLK3 (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clk1 Dual specificity protein kinase CLK1 (404 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clk2 Dual specificity protein kinase CLK2 (154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 245.24Molecular Weight (Monoisotopic): 245.0800AlogP: 0.46#Rotatable Bonds: 1
Polar Surface Area: 71.95Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.01CX Basic pKa: 2.32CX LogP: 0.65CX LogD: 0.65
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.71Np Likeness Score: -0.01

References

1. Tahtouh T, Durieu E, Villiers B, Bruyère C, Nguyen TL, Fant X, Ahn KH, Khurana L, Deau E, Lindberg MF, Sévère E, Miege F, Roche D, Limanton E, L'Helgoual'ch JM, Burgy G, Guiheneuf S, Herault Y, Kendall DA, Carreaux F, Bazureau JP, Meijer L..  (2022)  Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors.,  65  (2.0): [PMID:34928152] [10.1021/acs.jmedchem.1c01141]

Source